Kardium is developing a revolutionary medical device for the diagnosis and treatment of atrial fibrillation.
.
.
Location: Canada
Employees: 51-200
Total raised: $499M
Founded date: 2007
Funding Rounds 4
| Date | Series | Amount | Investors |
| 28.08.2026 | - | $31.25M | - |
| 09.07.2025 | - | $250M | Janus Hend... |
| 21.06.2024 | - | $104M | - |
| 26.01.2021 | IPO | $145M | - |
Mentions in press and media 15
| Date | Title | Description |
| 28.08.2026 | Kardium Secures Up To $31.25 Million From Canada For $125 Million Globe System Manufacturing Expansion | Kardium will receive up to $31.25 million from the Government of Canada to support a $125 million project expanding manufacturing capacity for its Globe Pulsed Field System in Vancouver, British Columbia. The federal funding is being provid... |
| 10.07.2026 | Global Pulsed Field Ablation Market and Forecast to 2032 | The global pulsed field ablation market was valued at USD 2 billion in 2025 and is projected to reach USD 8.9 billion by 2032, expanding at a CAGR of 23.7% during the forecast period. Pulsed field ablation (PFA) is an advanced non-thermal c... |
| 09.07.2025 | Kardium: $250 Million Raised For Launching Atrial Fibrillation Treatment | Kardium, the developer of the Globe Pulsed Field System for atrial fibrillation (AF), has raised $250 million in a financing round led by new investors, including Janus Henderson Investors and the Qatar Investment Authority, with participat... |
| 02.07.2025 | Kardium Raises $250M in Funding | Kardium, a Vancouver, Canada-based developer of the globe pulsed field system, a treatment for atrial fibrillation (AF), raised $250M in funding. The round was led by Janus Henderson Investors, Qatar Investment Authority (QIA), MMCAP, Piper... |
| 02.07.2025 | Kardium raises $250M as its pulsed field ablation system undergoes FDA review | The pulsed field ablation developer Kardium has collected $250 million in funding to gear up for the commercial expansion of its Globe system, planned for later this year. The Fierce 15 winner recently presented clinical results from a U.S.... |
| 21.06.2024 | Kardium's Globe System: A Revolutionary Breakthrough in Atrial Fibrillation Treatment | Kardium Inc., a pioneering medical technology company based in Vancouver, BC, Canada, recently announced a significant milestone in its journey towards transforming the treatment landscape for atrial fibrillation. Securing a substantial $10... |
| 21.06.2024 | Kardium: Atrial Fibrillation Treatment Company Raises $104 Million | Kardium, the developer of the Globe Mapping and Ablation System for the treatment of atrial fibrillation, has raised $104 million in a new financing round. This funding round is led by existing investor Fidelity Management & Research Co... |
| 12.06.2024 | Kardium nets $104M for its spherical pulsed field ablation catheter | Shortly after announcing positive clinical trial data from its pulsed field ablation treatment for irregular heart rhythms, Kardium has more good news to share: the company has secured $104 million in new funding. The proceeds will finance ... |
| 12.06.2024 | Kardium Raises $104M in Financing | Kardium Inc., the Vancouver, BC, Canada-based developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, raised US $104m in new financing. The round was led by existing investor Fidelity Management & R... |
| 12.06.2024 | Kardium: $104 Million Raised To Help Treat Atrial Fibrillation | Kardium, the developer of the Globe Mapping and Ablation System for the treatment of atrial fibrillation, announced it has raised $104 million in a new funding round. This funding round is led by existing investor Fidelity Management & ... |
Show more